Healthcare provider profile · identity verified

Robert Wagner, M.D.

Family Practice · GALESBURG, IL · NPI 1588663017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	252	52
Furosemide	Furosemide	250	37
Eliquis	Apixaban	195	24
Lisinopril	Lisinopril	170	40
Levothyroxine Sodium	Levothyroxine Sodium	164	31
Tamsulosin Hcl	Tamsulosin Hcl	162	26
Gabapentin	Gabapentin	139	29
Pantoprazole Sodium	Pantoprazole Sodium	136	30
Potassium Chloride	Potassium Chloride	135	28
Metoprolol Succinate	Metoprolol Succinate	127	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	17
Amlodipine Besylate	Amlodipine Besylate	120	33
Losartan Potassium	Losartan Potassium	114	29
Metformin Hcl	Metformin Hcl	112	22
Metoprolol Tartrate	Metoprolol Tartrate	89	18
Atenolol	Atenolol	88	13
Clopidogrel	Clopidogrel Bisulfate	88	18
Mirtazapine	Mirtazapine	86	14
Sertraline Hcl	Sertraline Hcl	85	19
Donepezil Hcl	Donepezil Hcl	83	18
Meloxicam	Meloxicam	78	12
Finasteride	Finasteride	70	12
Omeprazole	Omeprazole	68	15
Tramadol Hcl	Tramadol Hcl	66	23
Carvedilol	Carvedilol	65	16
Warfarin Sodium	Warfarin Sodium	65	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	60	26
Duloxetine Hcl	Duloxetine Hcl	59	suppressed
Trazodone Hcl	Trazodone Hcl	56	15
Pravastatin Sodium	Pravastatin Sodium	54	12
Jardiance	Empagliflozin	53	suppressed
Alprazolam	Alprazolam	51	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Memantine Hcl	Memantine Hcl	50	11
Cephalexin	Cephalexin	47	18
Lorazepam	Lorazepam	46	11
Spironolactone	Spironolactone	46	15
Simvastatin	Simvastatin	45	13
Buspirone Hcl	Buspirone Hcl	43	13
Citalopram Hbr	Citalopram Hydrobromide	43	12
Glipizide	Glipizide	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	13
Prednisone	Prednisone	42	17
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	suppressed
Levofloxacin	Levofloxacin	38	19
Albuterol Sulfate Hfa	Albuterol Sulfate	37	12
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Allopurinol	Allopurinol	33	13
Entresto	Sacubitril/Valsartan	32	suppressed
Midodrine Hcl	Midodrine Hcl	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Olanzapine	Olanzapine	28	suppressed
Ondansetron Odt	Ondansetron	28	14
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Calcium Acetate	Calcium Acetate	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	24	suppressed
Gemtesa	Vibegron	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	21	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	11
Pregabalin	Pregabalin	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Hydroxyurea	Hydroxyurea	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Topiramate	Topiramate	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Diazepam	Diazepam	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Famotidine	Famotidine	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error